GK
Gaurav Khandelwal
About Gaurav Khandelwal
Data last updated:
Gaurav Khandelwal is a Director at Rasik Remedies Private Limited (since 2009), Director at Safpure Lifesciences Private Limited (since 2013) and Director at Shri Shyam Prime Commodities Private Limited (since 2012). The companies operate in Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹106 Cr; the largest is Rasik Remedies Private Limited at ₹76.75 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 07 Jul 2009 | 2009 | ₹76.75 Cr (FY 2024) | Active | |
| Director | 22 Apr 2013 | 2013 | ₹29.57 Cr (FY 2025) | Active | |
| Director | 29 Mar 2012 | 2012 | ₹11 Lakh (FY 2020) | Active |
Board colleagues of Gaurav Khandelwal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kali Charan Das Khandelwal | 08073919 | Rasik Remedies Private Limited , Safpure Lifesciences Private Limited | Director |
| Kishan Gopal Khandelwal | 06987907 | Rasik Remedies Private Limited | Director |
| Narendra Kumar Khandelwal | 07859463 | Rasik Remedies Private Limited | Director |
| Poonam Khandelwal | 08310828 | Rasik Remedies Private Limited | Director |
| Saroj Khandelwal | 08073069 | Rasik Remedies Private Limited | Director |
| Sourabh Khandelwal | 02684188 | Rasik Remedies Private Limited , Safpure Lifesciences Private Limited and 1 more | Director |
| Swati Khandelwal | 08310884 | Rasik Remedies Private Limited | Director |
| Manju Khandelwal | 08607317 | Safpure Lifesciences Private Limited | Director |
| Pranita Khandelwal | 08696990 | Safpure Lifesciences Private Limited | Director |
| Keshav Khandelwal | 05240213 | Shri Shyam Prime Commodities Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Gaurav Khandelwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gaurav Khandelwal
Gaurav Khandelwal currently holds 3 directorships: Rasik Remedies Private Limited (Director, since 07 Jul 2009, revenue ₹76.75 Cr (FY 2024)); Safpure Lifesciences Private Limited (Director, since 22 Apr 2013, revenue ₹29.57 Cr (FY 2025)); Shri Shyam Prime Commodities Private Limited (Director, since 29 Mar 2012, revenue ₹11 Lakh (FY 2020)).
Gaurav Khandelwal was first appointed on 07 Jul 2009 as Director at Rasik Remedies Private Limited. The most recent appointment on record is 22 Apr 2013 at Safpure Lifesciences Private Limited.
The 3 current companies of Gaurav Khandelwal that report revenue have a combined latest revenue of ₹106 Cr: Rasik Remedies Private Limited ₹76.75 Cr (FY 2024); Safpure Lifesciences Private Limited ₹29.57 Cr (FY 2025); Shri Shyam Prime Commodities Private Limited ₹11 Lakh (FY 2020).
The current boards of Gaurav Khandelwal's companies include Kali Charan Das Khandelwal (Rasik Remedies Private Limited), Kishan Gopal Khandelwal (Rasik Remedies Private Limited), Narendra Kumar Khandelwal (Rasik Remedies Private Limited), Poonam Khandelwal (Rasik Remedies Private Limited), Saroj Khandelwal (Rasik Remedies Private Limited), Sourabh Khandelwal (Rasik Remedies Private Limited), among others.